Administrative Core
Administrative Core
批准号:
10261953
负责人:
Monica Kraft
金额:
$14.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-06-01 至 2026-05-31
关键词:
2019-nCoVAdherenceAdvisory CommitteesAllergic DiseaseAnionsArizonaAsthmaAttenuatedBiologicalBiological Response ModifiersCollaborationsCollectionCommunicationCommunitiesDataData AnalysesEnsureEthicsFosteringFunding OpportunitiesFutureGrantGuidelinesHealthHuman ResourcesImmuneImmune responseImmunologic FactorsImmunomodulatorsInfectionInflammationInflammatory ResponseInfluenza A virusInformation DisseminationInfrastructureInstitutionLipidsMediator of activation proteinMedical centerMolecularMonitorNatural ImmunityParticipantPerformancePhosphatidylglycerolsPhosphatidylinositolsProgram ReviewsPublicationsPulmonary Surfactant-Associated Protein ARecording of previous eventsRegulationResearchResearch ActivityResearch PersonnelResourcesRoleSamplingScheduleShippingTOLLIP geneTimeTranslatingTravelUnited States National Institutes of HealthUniversitiesVertebratesViralVirus DiseasesVisionWorkasthma exacerbationbaseclinical practiceconflict resolutioncostdata managementfollower of religion Jewishhuman subjectinnate immune mechanismsmeetingsmembernovel therapeuticsoperationprogramssuccesssurfactantsymposiumsynergism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This U19 Asthma and Allergic Diseases Cooperative Research Center (AACDRC) Program brings together a
team of investigators in three interactive projects and two cores to focus on the pathobiology of specific innate
immune mechanisms in viral infection and asthma. In the renewal of our AADCRC program, we will continue
to focus on the critical and often understudied innate immune factors surfactant protein-A (SP-A), the
anion lipids of surfactant, (palmitoyl-oleoyl-phosphatidylglycerol (POPG) and phosphatidylinositol (PI))
and Toll interacting protein (Tollip), an innate immune mediator known to cross talk with SP-A and the
anionic lipids. Each of these mediators works synergistically to modulate inflammatory and immunologic
responses in asthma and infection given their complementary functions. Our exciting preliminary data underpin
our program’s overall hypothesis that POPG/PI, Tollip and SP-A function as unique immune modulators
that attenuate the impact of specific viral infections (RV-C, Influenza A and SARS-CoV-2) in type-2
asthma. The investigators in this program have a long history of collaboration at the. University of Arizona and
National Jewish Health; Cedar Sinai Medical Center is now included in this renewal. The Administrative Core
(Core A) of this Program will perform an important role to maintain productive and vibrant collaboration, ensure
and track adherence to NIH and other relevant regulations and guidelines, and manage activities that will
continue to strengthen the research community surrounding this Program. The Administrative Core has the
following Specific Aims: (1) Manage the day-to-day administrative details and programmatic needs of the
AADCRC program by providing fiscal management, administering subcontracts, assuring that regulatory
requirements in are met, and monitoring of progress with program objectives; (2) Create an infrastructure to
facilitate communication between the projects, cores and. investigators, and NIH Program Directors and to
provide conflict resolution should it be necessary; (3) Assist with dissemination of research findings in a timely
fashion to the scientific community, both locally and nationally, and provide information to the public, including
study participants; 4) Implement the Infrastructure and Opportunity Fund for the AADCRC. Our proposal builds
upon our active and productive collaborations of over 20 years and will significantly enhance our understanding
of the innate molecular mechanisms underlying the interaction between type 2 inflammation in and viral
exacerbations of asthma. The strong synergy among our projects will accelerate progress toward novel
therapies by demonstrating that the innate immune components under study protect against viral
infection in asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center
-
批准号:10689774
-
项目类别:
-
资助金额:$254.73万
-
财政年份:2021
-
负责人:Monica Kraft
-
依托单位:
The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)
-
批准号:10204632
-
项目类别:
-
资助金额:$56.13万
-
财政年份:2020
-
负责人:Monica Kraft
-
依托单位:
Clinical Core
-
批准号:10216759
-
项目类别:
-
资助金额:$56.13万
-
财政年份:2020
-
负责人:Monica Kraft
-
依托单位:
University of Arizona-Banner Health All of Us Research Program
-
批准号:10338519
-
项目类别:
-
资助金额:$1150.0万
-
财政年份:2018
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10661671
-
项目类别:
-
资助金额:$46.95万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10473849
-
项目类别:
-
资助金额:$143.16万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10261957
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:10473850
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10473864
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Dysfunction of Innate Immunity in Asthma
-
批准号:9156365
-
项目类别:
-
资助金额:$142.82万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10661638
-
项目类别:
-
资助金额:$143.16万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10261952
-
项目类别:
-
资助金额:$143.35万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Dysfunction of Innate Immunity in Asthma
-
批准号:9305026
-
项目类别:
-
资助金额:$140.15万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:10661660
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
58th Annual Aspen Lung Conference
-
批准号:8910993
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2015
-
负责人:Monica Kraft
-
依托单位:
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
-
批准号:8337988
-
项目类别:
-
资助金额:$200.93万
-
财政年份:2012
-
负责人:Monica Kraft
-
依托单位:
Arizona/Duke Clinical Center for AsthmaNet
-
批准号:7936922
-
项目类别:
-
资助金额:$86.26万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
Airway Remondeling in Asthma: Modulation By IL-13
-
批准号:7917408
-
项目类别:
-
资助金额:$44.84万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:8325219
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
SP-A as an immune modulator
-
批准号:8321464
-
项目类别:
-
资助金额:$142.92万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
海外基金